This Article is waiting for corrections.
ARTICLE
28 October 2019
US FDA Highlights August 2019
On August 2, 2019, US Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor associated with severe morbidity ...